ACADIA Pharmaceuticals (ACAD)

ACADIA Pharmaceuticals A/S • ACADIA Pharmaceuticals GmbH • ACADIA Pharma Limited • CerSci Therapeutics Incorporated • Amorsa Therapeutics Inc. • Acadia Pharmaceuticals Holdings Inc. • Levo Therapeutics, Inc. ...

IRS number

61376651

ACAD stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Latest filings (excl ownership)

View all

8-K

Completion of Acquisition or Disposition of Assets

11 Dec 24

8-K

Departure of Directors or Certain Officers

6 Nov 24

Acadia Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operating Overview

6 Nov 24

S-8

Registration of securities for employees

23 Sep 24

8-K

Departure of Directors or Certain Officers

23 Sep 24

S-8 POS

Registration of securities for employees (post-effective amendment)

20 Aug 24

S-8 POS

Registration of securities for employees (post-effective amendment)

20 Aug 24

S-8 POS

Registration of securities for employees (post-effective amendment)

20 Aug 24

S-8 POS

Registration of securities for employees (post-effective amendment)

20 Aug 24

Transcripts

View all

ACAD

Earnings call transcript

2024 Q3

6 Nov 24

ACAD

Earnings call transcript

2024 Q2

6 Aug 24

ACAD

Earnings call transcript

2024 Q1

8 May 24

ACAD

Earnings call transcript

2023 Q4

27 Feb 24

ACAD

Earnings call transcript

2023 Q3

2 Nov 23

ACAD

Earnings call transcript

2023 Q2

2 Aug 23

ACAD

Earnings call transcript

2023 Q2

2 Aug 23

ACAD

Earnings call transcript

2023 Q1

8 May 23

ACAD

Earnings call transcript

2022 Q4

27 Feb 23

ACAD

Earnings call transcript

2022 Q3

3 Nov 22

Latest ownership filings

View all

Financial summary

Financial statements Chart ACAD financial data

Quarter (USD)	Sep 24	Jun 24	Mar 24	Dec 23
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	163.92 mm	163.92 mm	163.92 mm	163.92 mm	163.92 mm	163.92 mm
Cash burn (monthly)	6.33 mm	(no burn)	(no burn)	(no burn)	(no burn)	(no burn)
Cash used (since last report)	27.53 mm	n/a	n/a	n/a	n/a	n/a
Cash remaining	136.39 mm	n/a	n/a	n/a	n/a	n/a
Runway (months of cash)	21.6	n/a	n/a	n/a	n/a	n/a

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2024

ACAD institutional ownership history Ownership history

92.7% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	257	264	-2.7%
Opened positions	37	47	-21.3%
Closed positions	44	45	-2.2%
Increased positions	88	105	-16.2%
Reduced positions	81	77	+5.2%

13F shares	Current	Prev Q	Change
Total value	2.33 tn	2.57 tn	-9.2%
Total shares	154.32 mm	160.95 mm	-4.1%
Total puts	314.00 k	376.70 k	-16.6%
Total calls	900.60 k	828.60 k	+8.7%
Total put/call ratio	0.3	0.5	-23.3%

Largest owners	Shares	Value	Change
Baker Bros. Advisors	42.88 mm	$659.46 bn	0.0%
Vanguard	13.84 mm	$212.91 bn	+1.0%
RTW Investments	13.71 mm	$210.82 bn	0.0%
BlackRock	12.79 mm	$196.78 bn	NEW
STT State Street	5.97 mm	$91.88 bn	+3.0%
D. E. Shaw & Co.	3.50 mm	$53.91 bn	+19.4%
Fred Alger Management	3.19 mm	$49.01 bn	+17.8%
Geode Capital Management	2.88 mm	$44.23 bn	+1.1%
Palo Alto Investors	2.52 mm	$38.82 bn	+4.3%
First Trust Advisors	2.13 mm	$32.70 bn	+2.8%

Largest transactions	Shares	Bought/sold	Change
BlackRock	12.79 mm	+12.79 mm	NEW
BLK BlackRock	0.00	-12.06 mm	EXIT
Point72 Asset Management	0.00	-3.71 mm	EXIT
FMR	97.36 k	-2.27 mm	-95.9%
Marshall Wace	1.19 mm	-1.59 mm	-57.2%
Norges Bank	0.00	-1.45 mm	EXIT
EcoR1 Capital	0.00	-1.35 mm	EXIT
Man Group Limited	1.28 mm	+1.22 mm	+2131.9%
Nuveen Asset Management	1.36 mm	+921.14 k	+208.5%
Jupiter Asset Management	157.46 k	-903.38 k	-85.2%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

ACAD insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
9 Dec 24	Thomas Garner	RSU Common Stock	Grant	Acquire A	No	No	0	45,372	0.00	45,372
9 Dec 24	Thomas Garner	Stock Option Common Stock	Grant	Acquire A	No	No	18.76	235,849	4.42 mm	235,849
19 Nov 24	Mark C. Schneyer	Common Stock	Sell	Dispose S	No	Yes	16.81	10,259	172.45 k	53,302
19 Nov 24	James Kihara	Common Stock	Sell	Dispose S	No	Yes	16.81	4,073	68.47 k	19,863
19 Nov 24	Brendan Teehan	Common Stock	Sell	Dispose S	No	Yes	16.81	10,329	173.63 k	62,105
17 Nov 24	Mark C. Schneyer	Common Stock	Option exercise	Acquire M	No	No	0	9,913	0.00	63,561
17 Nov 24	Mark C. Schneyer	Common Stock	Option exercise	Acquire M	No	No	0	9,913	0.00	53,648
17 Nov 24	Mark C. Schneyer	RSU Common Stock	Option exercise	Dispose M	No	No	0	9,913	0.00	9,913
17 Nov 24	Mark C. Schneyer	RSU Common Stock	Option exercise	Dispose M	No	No	0	9,913	0.00	9,913
17 Nov 24	James Kihara	Common Stock	Option exercise	Acquire M	No	No	0	3,965	0.00	23,936